- Ermium presentation at the 19th World Congress of Basic and Clinical Pharmacology held in Glasgow further show the promise of Ermium compounds for SLE and other auto-immune disease indications.
- Ermium management team is expanding with the arrival of Dr Gerhard Müller who is our new Head of Medicinal Chemistry
- Ermium presentation at the 2023 EULAR, highlights the promise of Ermium therapeutic approach
- Ermium Therapeutics strengthens its management team with the appointment of Stéphane Durant des Aulnois as CFO
- Ermium Therapeutics strengthen its leadership team with the recent appointment of Dr Hélène Asnagli as head of biology / pharmacology
- Ermium Therapeutics appoints David Main, President and CEO of Notch Therapeutics, as an independent Board of Directors’ member